MURAKAMI Hiroshi | Third Department of Internal Medicine, Hirosaki University School of Medicine
スポンサーリンク
概要
- Murakami Hiroshiの詳細を見る
- 同名の論文著者
- Third Department of Internal Medicine, Hirosaki University School of Medicineの論文著者
関連著者
-
SUDA Toshihiro
Third Department of Internal Medicine, Hirosaki University School of Medicine
-
Matsui Jun
Department Of Endocrinology And Metabolism Hirosaki University Graduate School Of Medicine
-
Suda T
Department Of Endocrinology And Metabolism Hirosaki University Graduate School Of Medicine
-
Suda Toshihiro
Third Department Of Internal Medicine Hirosaki University School Of Medicine
-
Yamato Kazumi
Third Department Of Internal Medicine Hirosaki University School Of Medicine
-
Guan Jing-zhi
Department Of Endocrinology And Metabolism Hirosaki University Graduate School Of Medicine
-
Tamasawa Naoki
Department Of Endocrinology And Metabolism Hirosaki University Graduate School Of Medicine
-
MURAKAMI Hiroshi
Third Department of Internal Medicine, Hirosaki University School of Medicine
-
MATSUI Jun
Third Department of Internal Medicine, Hirosaki University School of Medicine
-
TAMASAWA Naoki
Third Department of Internal Medicine, Hirosaki University School of Medicine
-
Murakami Hiroshi
Department Of Endocrinology And Metabolism Hirosaki University Graduate School Of Medicine
-
GUAN Jing-Zhi
Third Department of Internal Medicine, Hirosaki University School of Medicine
-
Tanabe Jutarou
Department Of Endocrinology And Metabolism Hirosaki University Graduate School Of Medicine
-
TANABE Jutaro
Third Department of Internal Medicine, Hirosaki University School of Medicine
-
JINGZHI Guan
Third Department of Internal Medicine, Hirosaki University School of Medicine
著作論文
- Effects of Fluvastatin in Type 2 Diabetic Patients with Hyperlipidemia : Reduction in Cholesterol Oxidation Products and VCAM-1
- Clofibrate, a Peroxisome-Proliferator, Enhances Reverse Cholesterol Transport Through Cytochrome P450 Activation and Oxysterol Generation
- Plasma Levels of Soluble Vascular Adhesion Molecule-1 and Cholesterol Oxidation Product in Type 2 Diabetic Patients with Nephropathy